1-20 of 118
Thomas Cluzeau
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Secondary Genetic Alterations and Measurable Residual Disease in Core Binding Factor Acute Myeloid Leukemia - a Study from the Acute Leukemia French Intergroup

Loic Vasseur, Matthieu Duchmann, Nicolas Duployez, Emmanuel Raffoux, Celine Berthon, Mael Heiblig, Alexis Genthon, Thorsten Braun, Mathieu Leclerc, Delphine Lebon, Sylvain Chantepie, Jean-Baptiste Micol, Juliette Lambert, Christian Recher, Marie-Lorraine Chrétien, Thomas Cluzeau, Julien Vaidie, Jean-Valère Malfuson, Madalina Uzunov, Arnaud Pigneux, Pierre Peterlin, Sihem Tarfi, Pierre Hirsch, Dominique Penther, Eric Jourdan, Karine Celli-Lebras, Claude Preudhomme, Hervé Dombret, Jérôme Lambert, Nicolas Boissel, Raphael Itzykson
Journal: Blood
Blood (2024) 144 (Supplement 1): 227.
https://doi.org/10.1182/blood-2024-194060
Published: 2024
Journal Articles

Renew Trial in Progress: A Phase 3, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elritercept (KER-050) for the Treatment of Transfusion-Dependent Anemia in Adult Participants with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Neoplasms (MDS)

Rami S. Komrokji, Maria Diez-Campelo, Lynette C.Y. Chee, Thomas Cluzeau, Amy E. DeZern, Pierre Fenaux, Guillermo Garcia-Manero, Aristoteles Giagounidis, Uwe Platzbecker, Matteo Giovanni Della Porta, Valeria Santini, Mikkael A. Sekeres, Amer M. Zeidan, Rena Buckstein, Miranda Ross, Ying Jiang, Suresh Bobba, Montagu Hankin, Chris Materna, Christine Graham, Sanjay Thamake, Christopher Rovaldi, Dena Grayson, Jen L. Salstrom
Journal: Blood
Blood (2024) 144 (Supplement 1): 3228.1.
https://doi.org/10.1182/blood-2024-200797
Published: 2024
Journal Articles

Improved Outcomes in Paroxysmal Nocturnal Hemoglobinuria Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in 2011-2020: A Retrospective EBMT-Saawp Study

Camilla Frieri, Dirk-Jan Eikema, Sr., Joe Tuffnell, Brian Piepenbroek, Malek Benakli, Grzegorz Helbig, Thomas Cluzeau, Cécile Renard, Philippe Lewalle, Victoria Potter, Krzysztof Kalwak, Sr., Johan Maertens, Gerard Michel, Andrew Bruce McDonald, Péter Pál Reményi, Ladislav Sopko, Kazimierz Halaburda, Depei Wu, Zubeyde Nur Ozkurt, Xavier Poiré, Morag Griffin, Mahmoud Aljurf, Ashrafsadat Mousavi, Jose Antonio Pérez-Simón, Henrik Sengeloev, Ben Carpenter, Eric Deconinck, Arancha Bermúdez, Stéphanie Nguyen-Quoc, Matteo Parma, Ibrahim Yakoub-Agha, Shankara Paneesha, Lutz Peter Hermann Mueller, Regis Peffault De Latour, Austin G. Kulasekararaj, Antonio M Risitano
Journal: Blood
Blood (2024) 144 (Supplement 1): 305.
https://doi.org/10.1182/blood-2024-194716
Published: 2024
Journal Articles

Combining ESA and Luspatercept in Non-RS MDS Patients Having Failed ESA - Results of the Phase 1-2 Part a of the GFM Combola Study

Lionel Ades, Thomas Cluzeau, Thibault Comont, Lorea Aguinaga, Aspasia Stamatoullas, Mathieu Meunier, Emmanuel Gyan, Alice Garnier, Maud D'Aveni, Sylvain Thépot, Marie Sebert, Marius Moldovan, Anouk Walter Petrich, Karine Lemarie, Fatiha Chermat, Michaela Fontenay, Sylvie Chevret, Pierre Fenaux
Journal: Blood
Blood (2024) 144 (Supplement 1): 351.
https://doi.org/10.1182/blood-2024-204791
Published: 2024
Journal Articles

Improvements in Hematological Parameters and Quality of Life (QOL) with Elritercept (KER-050): Results from an Ongoing Phase 2 Trial in Participants with Lower-Risk (LR) Myelodysplastic Neoplasms (MDS)

Aristoteles Giagounidis, Monteserrat Arnan, Lynette C.Y. Chee, Thomas Cluzeau, Maria Diez-Campelo, Devendra Hiwase, David M Ross, Mikkael A. Sekeres, Shuhying Tan, David Valcarcel, Rena Buckstein, Bhavna Patel-Shah, Ming Yang, Ying Jiang, Jiani Yin, Suresh Bobba, Montagu Hankin, Chris Materna, Christine Graham, Sanjay Thamake, Christopher Rovaldi, Dena Grayson, Jen L. Salstrom
Journal: Blood
Blood (2024) 144 (Supplement 1): 1825.
https://doi.org/10.1182/blood-2024-203274
Published: 2024
Journal Articles

Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft- Versus -Host Disease : Results from Early Access Program in Europe

Florent Malard, Michael Loschi, Thomas Cluzeau, Raynier Devillier, Faezeh Legrand, Amandine Charbonnier, Delphine Lebon, Anne Huynh, Cecile Borel, Jean-Baptiste Méar, Faustine Lhomme, Hélène Labussière-Wallet, Déborah Desmier, Niels Moya, Martin Carré, Jérôme Cornillon, Vincent Camus, Patrice Ceballos, Francesco Saraceni, Corentin Orvain, Sylvain Chantepie, Jakob Daniel Rudzki, Marie-Anne Couturier, Patrice Chevallier, Clemence Mediavilla, Gabrielle Roth-Guepin, David Beauvais, Etienne Daguindau, Karin Bilger, Stefan A. Klein, Pedro Chorao, Sarah Altmeyer, Francesca Patriarca, Marion Bruelle, Emilie Plantamura, Gianfranco Pittari, Mohamad Mohty
Journal: Blood
Blood (2024) 144 (Supplement 1): 4903.
https://doi.org/10.1182/blood-2024-201251
Published: 2024
Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Neoplasms with Accompanying Paroxysmal Nocturnal Hemoglobinuria - a Study on Behalf of Cmwp and Saawp of the EBMT

Joanna Drozd-Sokolowska, Patrick Gilbert, Joe Tuffnell, Linda Koster, Uwe Platzbecker, Grzegorz Helbig, Pavel Jindra, Carlo Borghero, Matthias Eder, Thomas Schroeder, Katja Sockel, Thomas Cluzeau, Cecilia Isaksson, Nicolaus Kröger, Nuno Miranda, Montserrat Rovira, Urpu Salmenniemi, Henrik Sengeloev, Simona Sica, Peter A. Von Dem Borne, Francesco Onida, Carmelo Gurnari, Christoph Scheid, Kavita K Raj, Regis Peffault De Latour, Antonio M Risitano, Marie Robin, Donal P McLornan
Journal: Blood
Blood (2024) 144 (Supplement 1): 4949.
https://doi.org/10.1182/blood-2024-203009
Published: 2024
Journal Articles

Enasidenib (ENA) Monotherapy in Patients with IDH2 mutated Myelodysplastic Syndrome (MDS), the Ideal Phase 2 Study By the GFM and Emsco Groups

Marie Sebert, Sylvie Chevret, Sophie Dimicoli-Salazar, Thomas Cluzeau, Odile Rauzy, Aspasia Stamatoulas Bastard, Kamel Laribi, Gaelle Fossard, Sylvain Thépot, Silke Gloaguen, Kristell Desseaux, Norbert Vey, Pierre Peterlin, Anne-Laure Taksin, Caroline Lejeune, Sophie Park, Anne Banos, Aristoteles Giagounidis, Emmanuel Gyan, Mario Ojeda-Uribe, Stefanie Groepper, Fatiha Chermat, Emmanuelle Clappier, Uwe Platzbecker, Pierre Fenaux, Lionel Ades
Journal: Blood
Blood (2024) 144 (Supplement 1): 1839.
https://doi.org/10.1182/blood-2024-201317
Published: 2024
Journal Articles

Preliminary Safety, Efficacy, and Molecular Characterization of Emavusertib (CA-4948) in Relapsed/Refractory Acute Myeloid Leukemia Patients

Eric S. Winer, David Sallman, Adolfo De la Fuente Burguera, Amit Verma, Katharina Goetze, Yasmin Abaza, James P. Dugan, Thomas Cluzeau, Eduardo Rodriguez Arboli, Alice Mims, Stefanie Groepper, Itay Zilbershatz, Jane L. Liesveld, Walter Fiedler, Stefano R Tarantolo, Lionel Ades, Nikolaos Papadantonakis, Christoph Schliemann, Gaurav S Choudhary, Maureen Lane, Wanying Zhao, Ashish Jain, Cole Gallagher, Guillermo Garcia-Manero
Journal: Blood
Blood (2024) 144 (Supplement 1): 737.
https://doi.org/10.1182/blood-2024-207953
Published: 2024
Journal Articles

Switch of Asparaginase Formulation Based on Antibody Monitoring in Adults with Philadelphia-Negative Adult Lymphoblastic Leukemia. Results of the Graall-2014 Trial

Marie Balsat, Corentin Orvain, Jean-François Benoist, Nicolas De Roux, Thibaut Leguay, Françoise Huguet, Patrice Chevallier, Cendrine Josson, Christine Bain-Wendlinger, Yosr Hicheri, Anne Thiebaut, Martine Escoffre-Barbe, Thomas Cluzeau, Florence Pasquier, Ana Berceanu, Florence Van Obbergh, Jamilé Frayfer, Gaëlle Guillerm, Victoria Cacheux, Isabelle Plantier, Laurence Sanhes, Chantal Himberlin, Jacques Vargaftig, Sabine Tricot, Yves Chalandon, Carlos Graux, Véronique Lheritier, Hervé Dombret, Hunault-Berger Mathilde, Nicolas Boissel
Journal: Blood
Blood (2024) 144 (Supplement 1): 1434.
https://doi.org/10.1182/blood-2024-199110
Published: 2024
Journal Articles

A Phase II Study Evaluating the Efficacy and Safety of Imetelstat in Patients with Advanced Myelodysplastic Neoplasms or AML Failing HMA-Based Therapy - Interim Analysis Results of the Impress Study

Uwe Platzbecker, Steven W Lane, Alice Garnier, Thomas Cluzeau, Odile Rauzy, Katharina S. S. Götze, Aristoteles Giagounidis, Deepak Singhal, Aicha Kopecky, Fatiha Chermat, Lionel Ades
Journal: Blood
Blood (2024) 144 (Supplement 1): 3222.
https://doi.org/10.1182/blood-2024-194185
Published: 2024
Journal Articles

Hematologic Improvement and Fatigue Reduction with Elritercept (KER-050) in Participants with Lower-Risk (LR) Myelodysplastic Neoplasms (MDS) with Non-Transfusion Dependent Anemia: New Analyses from an Ongoing Phase 2 Trial

Shuhying Tan, Montserrat Arnan, Lynette C.Y. Chee, Thomas Cluzeau, Maria Diez-Campelo, Aristoteles Giagounidis, Devendra Hiwase, David M Ross, Mikkael A. Sekeres, David Valcarcel, Bhavna Patel-Shah, Ming Yang, Ying Jiang, Jiani Yin, Suresh Bobba, Montagu Hankin, Chris Materna, Christine Graham, Sanjay Thamake, Christopher Rovaldi, Dena Grayson, Jen L. Salstrom
Journal: Blood
Blood (2024) 144 (Supplement 1): 4591.
https://doi.org/10.1182/blood-2024-208186
Published: 2024
Journal Articles

Long Term Follow-up Data after Consolidation Therapy with Ponatinib in Combination with Cytarabine in Patients with FLT3 Mutated Acute Myeloid Leukemia in First Complete Remission

Thibaut Leguay, Laurène Fenwarth, Thomas Cluzeau, Anne Vekoff, Etienne Lengline, Juliette Lambert, Denis Caillot, Mathilde Hunault, Jean-Valère Malfuson, Sylvain Chantepie, Emmanuelle Tavernier, Berengere Gruson, José Fernandes, Pierre Peterlin, Melody Fort, Laure Morisset, Herve Dombret, Claude Preudhomme, Arnaud Pigneux, Philippe Rousselot
Journal: Blood
Blood (2024) 144 (Supplement 1): 2905.
https://doi.org/10.1182/blood-2024-209998
Published: 2024
Journal Articles

Single-Agent Subcutaneous Blinatumomab for Advanced B-Cell Acute Lymphoblastic Leukemia: Long-Term Follow-up from a Phase 1b Dose Expansion Cohort

Elias Jabbour, Gerhard Zugmaier, Pilar Martinez Sanchez, Jose J. Rifon, Vaibhav Agrawal, Ryan D Cassaday, Thomas Cluzeau, Françoise Huguet, Vladan Vucinic, Boris Böll, Anita W. Rijneveld, Mar Tormo, Maher Abdul-Hay, Paul R Gordon, Alessandro Rambaldi, Hagop M. Kantarjian
Journal: Blood
Blood (2024) 144 (Supplement 1): 1440.
https://doi.org/10.1182/blood-2024-205662
Published: 2024
Journal Articles

Treatments and Outcomes of Adult Patients with AML in the Real-Life - First Report of the French Observational ALFA-PPP Study

Hervé Dombret, Alexandra Coelho, Laurène Fenwarth, Jean-Baptiste Micol, Lionel Ades, Thomas Cluzeau, Emmanuel Raffoux, Sylvain Chantepie, Pierre Arnautou, Mathieu Leclerc, Delphine Lebon, Thorsten Braun, Ollivier Legrand, Claire Bories, Céline Berthon, Juliette Lambert, Ahmad Aljijakli, Emilie Lemasle, Pascal Turlure, Benjamin Carpentier, Jamile Frayfer, Stephanie Haiat, Ambroise Marcais, Isabelle Plantier, Kevin-James Wattebled, Madalina Uzunov, Iona Vaida, Mael Heiblig, Lauris Gastaud, Laure Farnault, Dominique Penther, Nicole Raus, Renaud Buffet, Karine Celli-Lebras, Claude Preudhomme, Nicolas Duployez, Raphael Itzykson, Stephane De Botton
Journal: Blood
Blood (2024) 144 (Supplement 1): 2424.
https://doi.org/10.1182/blood-2024-207226
Published: 2024
Journal Articles

Venetoclax-Based Therapy Versus Intensive Chemotherapy Followed By Allogeneic-Stem Cell Transplantation for High-Risk Elderly Acute Myeloid Leukemia

Alexandre Iat, Jan Philipp Bewersdorf, Julia Gilhodes, Yiwen Liu, Rory M. Shallis, Leora Boussi, Andrius Zucenka, Rebecca P. Bystrom, Daniel J. DeAngelo, Guillaume Berton, Amel Soua, Kelly Ling, Luis E. Aguirre, Richard M Stone, Marlise R. Luskin, Jacqueline S. Garcia, Eric S. Winer, Evan C. Chen, Martha Wadleigh, Aaron D. Goldberg, Amer M. Zeidan, Thomas Cluzeau, Shai O. Shimony, Maximilian Stahl, Sylvain Garciaz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1508.
https://doi.org/10.1182/blood-2024-207045
Published: 2024
Journal Articles

The ELEMENT-MDS Trial: A Phase 3 Randomized Study Evaluating Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Non-Transfusion-Dependent, Lower-Risk Myelodysplastic Syndromes

Amer M. Zeidan, Rami S. Komrokji, Rena Buckstein, Valeria Santini, Shelonitda Rose, Priya Malini, Glen Lew, Dimple Aggarwal, Karen L. Keeperman, Huijing Jiang, Ana Carolina Giuseppi, Jennie Zhang, Thomas Cluzeau, Jake Shortt, Uwe Platzbecker
Journal: Blood
Blood (2023) 142 (Supplement 1): 6503.
https://doi.org/10.1182/blood-2023-178635
Published: 2023
Journal Articles

Phase I/II Clinical Trial Evaluating Azacitidine + Venetoclax + Donor Lymphocyte Infusion in Post-Transplant Relapse Myelodysplastic Syndromes and Acute Myeloid Leukemia: Preliminary Results of Ventograft, a GFM Study

Thomas Cluzeau, Marie Sebert, Michael Loschi, Lionel Ades, Sylvain Thepot, Martin Carre, Nicolas Duployez, Rosa Sapena, Fatiha Chermat, Claude Preudhomme, Pierre Fenaux, Marie Robin
Journal: Blood
Blood (2023) 142 (Supplement 1): 3246.
https://doi.org/10.1182/blood-2023-178021
Published: 2023
Journal Articles

Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft-Versus-Host Disease : Results from Early Access Program in Europe

Florent Malard, Michael Loschi, Thomas Cluzeau, Faezeh Legrand, Jean-Baptiste Méar, Faustine Lhomme, Anne Huynh, Sarah Guenounou, Cécile Borel, Déborah Desmier, Niels Moya, Amandine Charbonnier, Delphine Lebon, Hélène Labussière-Wallet, Corentin Orvain, Sylvain Chantepie, Martin Carre, Vincent Camus, Marie-Anne Couturier, Jérôme Cornillon, Patrice Chevallier, Clemence Mediavilla, Patrice Ceballos, David Beauvais, Etienne Daguindau, Karin Bilger, Stefan Klein, Marion Bruelle, Emilie Plantamura, Mohamad Mohty
Journal: Blood
Blood (2023) 142 (Supplement 1): 3553.
https://doi.org/10.1182/blood-2023-185751
Published: 2023
Journal Articles

Post-Transplant Lymphoproliferative Disorders (PTLD) in Real Life: Data from the French K-Virogref Registry on 525 Adult Patients

Antoine Tichadou, Elise Toussaint, Luc Matthieu Fornecker, Veronique Morel, Inès Boussen, Damien Roos Weil, Marine Baron, Madalina Uzunov, Laetitia Souchet, Louise Roulin, Nabih Azar, Stéphane Lepretre, Bijou Fontanet, Caroline Jacquet, Eric Durot, David Boutboul, Felipe Suarez, Thomas Cluzeau, Mohamed Touati, Emmanuel Bachy, Roch Houot, Fabrice Jardin, Romain Guieze, Loic Ysebaert, Laure Farnault de Lassus, Sylvain Choquet
Journal: Blood
Blood (2023) 142 (Supplement 1): 443.
https://doi.org/10.1182/blood-2023-189133
Published: 2023